Van Hoogstraten IMW, von Blomberg BME, Boden D, Kraal G, & Scheper RJ (1994) Non-sensitizing percutaneous skin contacts prevent subsequent induction of immune tolerance
Results vary, but clinical studies show that patients combining GLP-1 Agonist with lifestyle changes can achieve significant weight loss, often averaging around 15% of their starting body weight over about a year
The authors conclude that past respiratory disorders maximally contribute to IPF risk, followed by known IPF comorbidities, metabolic diseases, cardiovascular abnormalities, and diseases of the eye, with the overall pattern of the importance ranking substantially invariant across the sexes
There are two types of this virus: HSV-1, which typically causes oral herpes, and HSV-2, which is more commonly associated with genital herpes